MedPath

Clinical Study on the Effect of Virechana in Sthaulya Vis-Vas obesity.

Phase 2
Conditions
Health Condition 1: null- With controlled Systemic disorders
Registration Number
CTRI/2018/06/014348
Lead Sponsor
Government Ayurved College Nagpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.patients of clinical features of Sthaulya.

2.body mass index from 25kg/m2 to 35kg/m2.

3.patients of Sthaulya with controled HTN and DM.

4.Patients with total cholesterol less than 300mg/dl

Exclusion Criteria

1.Patients of obesity due to hypothyroidism Cushingâ??s syndrome,

Steroid induced obesity or Obesity due to any other systemic

disorders.

2.Drug induced obesity for example Hormonal replacement therapy,

calcium channel blockers, consumption of anabolic steroids etc.

3.Pregnant females & lactating mothers.

4.Patients who are currently participating in other clinical trials (since

last six months).

5.Obesity because of heredity will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)To evaluate the effect of Snehpana on body <br/ ><br>mass index, waist hip ratio and lipid profile. <br/ ><br>2)To evaluate the effect of Snehpana and <br/ ><br>Virechana separately on body mass index, waist <br/ ><br>hip ratio and lipid profile. <br/ ><br>3)To evaluate the effect of Snehpana followed by <br/ ><br>Virechana and Dashang Guggul as Shamana <br/ ><br>drug on body mass index, waist hip ratio and <br/ ><br>lipid profile. <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 1)On zero day i.e. B.T.value <br/ ><br>2)Rukshana Pachana Kvath will be given for 5 <br/ ><br>days. <br/ ><br>3)From 6th day Snehapana will be administered <br/ ><br>for seven days and assessment will be done on <br/ ><br>13th day. <br/ ><br>4)Virechana will be given on 16 th day and <br/ ><br>assessment will be done on 21 rst day. <br/ ><br>5) Final assessment will be done on 51 rst day <br/ ><br>i.e. Dashanga Guggulu will be given for 30 days. <br/ ><br> <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
II} Secondary objectives: <br/ ><br>1) To review and study literature of Sthaulya. <br/ ><br>2) To review and study literature of Obesity. <br/ ><br>Timepoint: One and half year <br/ ><br> <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath